Cargando…
Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy
BACKGROUND: Cardiac power (CP; CP = 0.222 × cardiac output × mean blood pressure) output in patients with heart failure has been studied previously, but its importance in patients with hypertrophic cardiomyopathy (HCM) remains unclear. The present study aimed to explore the role of normalized CP (no...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347308/ https://www.ncbi.nlm.nih.gov/pubmed/37456301 http://dx.doi.org/10.21037/qims-22-1119 |
_version_ | 1785073519449604096 |
---|---|
author | Li, Qing Gao, Xuelian Zhou, Zhen Zhang, Hongkai Li, Wenjie Gao, Yifeng Bo, Kairui Wang, Hui Wang, Rui Sun, Zhonghua Xu, Lei |
author_facet | Li, Qing Gao, Xuelian Zhou, Zhen Zhang, Hongkai Li, Wenjie Gao, Yifeng Bo, Kairui Wang, Hui Wang, Rui Sun, Zhonghua Xu, Lei |
author_sort | Li, Qing |
collection | PubMed |
description | BACKGROUND: Cardiac power (CP; CP = 0.222 × cardiac output × mean blood pressure) output in patients with heart failure has been studied previously, but its importance in patients with hypertrophic cardiomyopathy (HCM) remains unclear. The present study aimed to explore the role of normalized CP (normalized CP = CP/ventricle mass) in assessing cardiac function in patients with HCM with normal ejection fraction using cardiac magnetic resonance (CMR). METHODS: This cross-sectional study enrolled 99 patients with HCM who underwent CMR from December 2020 to January 2022 at Beijing Anzhen Hospital, and these patients were classified into heart failure or non-heart failure subgroups. Meanwhile, a control group comprising 65 gender- and age-matched healthy volunteers was also enrolled. The baseline clinical characteristics and cardiac functional parameters were compared between the patients with HCM and the controls, and multivariable linear regression analysis was performed to analyze the relationship between normalized CP and the relevant factors. RESULTS: Significantly higher CP (1.19 vs. 1.01 W; P=0.03) but lower normalized CP (0.73 vs. 1.12 W/100 g; P<0.001) were found in patients with HCM as compared with the controls. Multivariable analysis showed that HCM correlated well with normalized CP [β=−0.235; 95% confidence interval (CI): −0.341 to −0.129; P<0.001]. In the HCM group, there were 34 cases with heart failure and 65 with non-heart failure, and the patients with HCM with heart failure showed similar CP (1.14 vs. 1.24 W; P=0.06) but significantly lower normalized CP (0.54 vs. 0.78 W/100 g; P<0.001). The correlation analysis of normalized CP and functional parameters revealed that normalized CP was inversely correlated with left ventricle mass/body surface area (R=−0.509; 95% CI: −0.646 to −0.341; P<0.001) in patients with HCM. CONCLUSIONS: Normalized CP decreased significantly and was negatively correlated with ventricle mass, indicating impaired cardiac pump function in patients with HCM. Normalized CP might play a critical role in detecting and evaluating impaired cardiac pump function in patients with HCM with preserved ejection fraction. |
format | Online Article Text |
id | pubmed-10347308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-103473082023-07-15 Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy Li, Qing Gao, Xuelian Zhou, Zhen Zhang, Hongkai Li, Wenjie Gao, Yifeng Bo, Kairui Wang, Hui Wang, Rui Sun, Zhonghua Xu, Lei Quant Imaging Med Surg Original Article BACKGROUND: Cardiac power (CP; CP = 0.222 × cardiac output × mean blood pressure) output in patients with heart failure has been studied previously, but its importance in patients with hypertrophic cardiomyopathy (HCM) remains unclear. The present study aimed to explore the role of normalized CP (normalized CP = CP/ventricle mass) in assessing cardiac function in patients with HCM with normal ejection fraction using cardiac magnetic resonance (CMR). METHODS: This cross-sectional study enrolled 99 patients with HCM who underwent CMR from December 2020 to January 2022 at Beijing Anzhen Hospital, and these patients were classified into heart failure or non-heart failure subgroups. Meanwhile, a control group comprising 65 gender- and age-matched healthy volunteers was also enrolled. The baseline clinical characteristics and cardiac functional parameters were compared between the patients with HCM and the controls, and multivariable linear regression analysis was performed to analyze the relationship between normalized CP and the relevant factors. RESULTS: Significantly higher CP (1.19 vs. 1.01 W; P=0.03) but lower normalized CP (0.73 vs. 1.12 W/100 g; P<0.001) were found in patients with HCM as compared with the controls. Multivariable analysis showed that HCM correlated well with normalized CP [β=−0.235; 95% confidence interval (CI): −0.341 to −0.129; P<0.001]. In the HCM group, there were 34 cases with heart failure and 65 with non-heart failure, and the patients with HCM with heart failure showed similar CP (1.14 vs. 1.24 W; P=0.06) but significantly lower normalized CP (0.54 vs. 0.78 W/100 g; P<0.001). The correlation analysis of normalized CP and functional parameters revealed that normalized CP was inversely correlated with left ventricle mass/body surface area (R=−0.509; 95% CI: −0.646 to −0.341; P<0.001) in patients with HCM. CONCLUSIONS: Normalized CP decreased significantly and was negatively correlated with ventricle mass, indicating impaired cardiac pump function in patients with HCM. Normalized CP might play a critical role in detecting and evaluating impaired cardiac pump function in patients with HCM with preserved ejection fraction. AME Publishing Company 2023-04-20 2023-07-01 /pmc/articles/PMC10347308/ /pubmed/37456301 http://dx.doi.org/10.21037/qims-22-1119 Text en 2023 Quantitative Imaging in Medicine and Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Li, Qing Gao, Xuelian Zhou, Zhen Zhang, Hongkai Li, Wenjie Gao, Yifeng Bo, Kairui Wang, Hui Wang, Rui Sun, Zhonghua Xu, Lei Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy |
title | Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy |
title_full | Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy |
title_fullStr | Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy |
title_full_unstemmed | Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy |
title_short | Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy |
title_sort | impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347308/ https://www.ncbi.nlm.nih.gov/pubmed/37456301 http://dx.doi.org/10.21037/qims-22-1119 |
work_keys_str_mv | AT liqing impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT gaoxuelian impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT zhouzhen impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT zhanghongkai impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT liwenjie impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT gaoyifeng impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT bokairui impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT wanghui impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT wangrui impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT sunzhonghua impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy AT xulei impairedcardiacpumpfunctionassessmentwithnormalizedcardiacpowerusingcardiacmagneticresonanceinpatientswithhypertrophiccardiomyopathy |